Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by jomagon Jan 04, 2019 9:58am

71 Views

Post# 29185733

House positions

House Positions for C:ICO from 20190104 to 20190104

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	801,500	56,292	0.07	900	72	0.08	800,600	-56,220
59 PI	200,000	16,000	0.08	1,700	123	0.072	198,300	-15,877
7 TD Sec	250,200	18,776	0.075	131,400	9,678	0.074	118,800	-9,098
80 National Bank	124,000	9,920	0.08	45,000	3,375	0.075	79,000	-6,545
85 Scotia	20,000	1,500	0.075	0			20,000	-1,500
57 Interactive	4,800	360	0.075	0			4,800	-360
13 Instinet	4,000	300	0.075	10,000	800	0.08	-6,000	500
79 CIBC	2,000	150	0.075	20,000	1,570	0.079	-18,000	1,420
19 Desjardins	30,000	2,150	0.072	90,000	6,650	0.074	-60,000	4,500
99 Jitney	230,000	17,700	0.077	668,000	52,105	0.078	-438,000	34,405
1 Anonymous	597,500	44,380	0.074	1,297,000	93,155	0.072	-699,500	48,775